# An Intermediate Expanded Use Trial of DFMO

> **NCT03581240** · — · AVAILABLE · sponsor: **Giselle Sholler**

## Conditions studied

- Neuroblastoma
- Medulloblastoma
- Typical Teratoid Rhabdoid Tumor
- Embryonal Tumor With Abundant Neuropil and True Rosettes
- Ependymoblastoma
- Medulloepithelioma

## Interventions

- **DRUG:** eflornithine HCl

## Key facts

- **NCT ID:** NCT03581240
- **Lead sponsor:** Giselle Sholler
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03581240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03581240, "An Intermediate Expanded Use Trial of DFMO". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03581240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*